Phage-Derived Depolymerase as an Antibiotic Adjuvant Against Multidrug-Resistant Acinetobacter baumannii

Деполимераза фагового происхождения в качестве адъюванта антибиотиков против мультирезистентной Acinetobacter baumannii
Sharon Shui Yee Leung, Liming Bian, Weihao Yuan, Jiang Xia, Miao Yun Xu, Miao Liu, Xi Chen, Yannan Liu, Pengfei Zhang
2022-03-25

antibiotic adjuvantbiofilm disruptioncolistinmultidrug-resistant Acinetobacter baumanniiphage-derived depolymerase
ABSTRACT Bacteriophage-encoded depolymerases are responsible for degrading capsular polysaccharides (CPS), lipopolysaccharides (LPS) and exopolysachcharides (EPS) of the host bacteria during phage invasion. They have been considered as promising antivirulence agents in controlling bacterial infections, including those caused by drug-resistant bacteria. This feature inspires a hope of utilizing these enzymes to disarm the polysaccharide capsid of the bacterial cells, which then strengthens the action of antibiotics. Here we have identified, cloned, and expressed a depolymerase Dpo71 from a bacteriophage specific for the gram-negative (G-ve) bacterium Acinetobacter baumannii in the heterologous host E. coli . Dpo71 sensitizes the multidrug-resistant (MDR) A. baumannii to the host immune attack, and also acts as an adjuvant to assist or boost the action of antibiotics, for example colistin. Specifically, Dpo71 at 10 µg/ml enables a complete bacterial eradication by human serum at 50% volume ratio. Dpo71 inhibits biofilm formation and disrupts the pre-formed biofilm. Combination of Dpo71 could significantly enhance the antibiofilm activity of colistin, and improve the survival rate of A. baumannii infected Galleria mellonella . Dpo71 retains the strain-specificity of the parent phage from which Dpo71 is derived: the phage-sensitive A. baumannii strains respond to Dpo71 treatment, whereas the phage-insensitive strains do not. This indicates that Dpo71 indeed is responsible for the host specificity of bacteriophages. In summary, our work demonstrates the feasibility of using recombinant depolymerases as an antibiotic adjuvants to supplement the development of new antibacterials and to battle against MDR pathogens.
1
Capsule removal by Dpo71 enhanced colistin binding and outer-membrane destabilization, thereby strengthening colistin’s bactericidal activity.
2
Dpo71 at 10 μg/ml enabled complete eradication of MDR A. baumannii by human serum at a 50% volume ratio.
3
Dpo71 improved survival of A. baumannii-infected Galleria mellonella when combined with colistin and retained the parent phage’s strain specificity.
4
Dpo71 inhibited biofilm formation, disrupted established biofilms, and significantly enhanced colistin antibiofilm activity.
5
The recombinant phage depolymerase Dpo71 was identified and expressed heterologously in Escherichia coli for targeting multidrug-resistant Acinetobacter baumannii.

Multidrug-resistant Acinetobacter baumannii and its bacterial capsule, biofilms, and infection model

The effects and mechanisms of phage-derived depolymerase Dpo71 as an antibiotic adjuvant, including capsule degradation, antibiotic potentiation, antibiofilm activity, and strain specificity

Publication Details
Publication Date
2022-03-25
Journal
Publisher
ISSN
Cited by
85
Access Type
Author Information
Authors
Sharon Shui Yee Leung
Liming Bian
Weihao Yuan
Jiang Xia
Miao Yun Xu
Miao Liu
Xi Chen
Yannan Liu
Pengfei Zhang
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%